|
|
|
HYANNIS — One day after a recount reversed an earlier tally approving the restructuring of Barnstable's town government, one of the proposal's authors took out papers to reintroduce the issue at the 2011 town election.
APTARE, Inc, an enterprise storage resource management leader, today announced that it has achieved Ready for IBM Tivoli software validation for APTARE StorageConsole Backup Manager. This designation confirms that APTARE...
So Richard Clark is on the hunt. The Merck CEO said early this month that he is looking to acquire biotechnology companies, preferring to spend in the single-digit billions of dollars. One company in particular–Amylin...
Merger-related cuts at Merck and Pfizer show how the mighty drug industry has fallen. After Merck's merger with Schering-Plough closed last week, top executives fanned out across the world to reassure nervous employees. ) Chief...
NEW YORK (Reuters) - Drugmakers who have complained for years about caution and unpredictability at the U.S. Food and Drug Administration see signs the climate for reviewing new medicines may be improving.
If you've driven from Charlotte to Myrtle Beach down Highway 9, there's a good chance you didn't notice Chesterfield, S.C., when you passed through. It sits quietly off the highway, tucked between Pageland to the west and...
HYANNIS — The Barnstable town government's impending face-lift, approved by one vote, will get a second look next week. Centerville resident Jeffrey Wilkinson submitted the required number of signatures yesterday to call for a...
NEW YORK (Reuters) - Merck & Co (MRK.N: Quote, Profile, Research, Stock Buzz) CEO Richard Clark, who just completed the $41 billion purchase of Schering-Plough Corp, said investors are expecting the company by mid-2010 to...
Larger Merck says merger will actually increase R&D efficiency pharmatimes.com 05 November 2009 The new Merck & Co has opened its doors for business, and the company has been laying out its plans for future growth now that...
TRENTON, N.J. – The new Merck & Co. has become the world’s second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing. A day after closing its $41.1 billion...
